US Patent 12018059 Human amylin analog polypeptides and methods of use
Patent 12018059 was granted and assigned to i2O Therapeutics, Inc. on June, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 27 Jun, 2024
Golden AI
Edits made to:
Infobox (+18 properties)
Article (+252 characters)
US Patent 12018059 Human amylin analog polypeptides and methods of use
Article
Patent abstract
This invention relates to isolated polypeptides that are analogs of human amylin. The disclosed amylin analog polypeptides have beneficial physicochemical properties relative to endogenous amylin, such as longer elimination half-lives (t
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
James M. Way0
Ved P. Srivastava0
William Blackwell0
Date of Patent
June 25, 2024
0Patent Application Number
165989150
Date Filed
October 10, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12018059 Human amylin analog polypeptides and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
